Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 2
2016 1
2017 1
2018 1
2020 1
2021 9
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection.
Tamir H, Noy-Porat T, Melamed S, Cherry-Mimran L, Barlev-Gross M, Alcalay R, Yahalom-Ronen Y, Achdout H, Politi B, Erez N, Weiss S, Rosenfeld R, Epstein E, Mazor O, Makdasi E, Paran N, Israely T. Tamir H, et al. Among authors: noy porat t. Nat Commun. 2024 Apr 16;15(1):3265. doi: 10.1038/s41467-024-47328-y. Nat Commun. 2024. PMID: 38627363 Free PMC article.
Centaur antibodies: Engineered chimeric equine-human recombinant antibodies.
Rosenfeld R, Alcalay R, Zvi A, Ben-David A, Noy-Porat T, Chitlaru T, Epstein E, Israeli O, Lazar S, Caspi N, Barnea A, Dor E, Chomsky I, Pitel S, Makdasi E, Zichel R, Mazor O. Rosenfeld R, et al. Among authors: noy porat t. Front Immunol. 2022 Aug 19;13:942317. doi: 10.3389/fimmu.2022.942317. eCollection 2022. Front Immunol. 2022. PMID: 36059507 Free PMC article.
A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.
Fisher M, Levy H, Fatelevich E, Afrimov Y, Ben-Shmuel A, Rosenfeld R, Noy-Porat T, Glinert I, Sittner A, Biber A, Belkin A, Bar-David E, Puni R, Levy I, Mazor O, Weiss S, Mechaly A. Fisher M, et al. Among authors: noy porat t. Microbiol Spectr. 2021 Oct 31;9(2):e0087021. doi: 10.1128/Spectrum.00870-21. Epub 2021 Oct 6. Microbiol Spectr. 2021. PMID: 34612689 Free PMC article.
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants.
Makdasi E, Zvi A, Alcalay R, Noy-Porat T, Peretz E, Mechaly A, Levy Y, Epstein E, Chitlaru T, Tennenhouse A, Aftalion M, Gur D, Paran N, Tamir H, Zimhony O, Weiss S, Mandelboim M, Mendelson E, Zuckerman N, Nemet I, Kliker L, Yitzhaki S, Shapira SC, Israely T, Fleishman SJ, Mazor O, Rosenfeld R. Makdasi E, et al. Among authors: noy porat t. Cell Rep. 2021 Sep 7;36(10):109679. doi: 10.1016/j.celrep.2021.109679. Epub 2021 Aug 21. Cell Rep. 2021. PMID: 34464610 Free PMC article.
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
Barlev-Gross M, Weiss S, Paran N, Yahalom-Ronen Y, Israeli O, Nemet I, Kliker L, Zuckerman N, Glinert I, Noy-Porat T, Alcalay R, Rosenfeld R, Levy H, Mazor O, Mandelboim M, Mendelson E, Beth-Din A, Israely T, Mechaly A. Barlev-Gross M, et al. Among authors: noy porat t. J Infect Dis. 2021 Aug 16;224(4):616-619. doi: 10.1093/infdis/jiab278. J Infect Dis. 2021. PMID: 34398244 Free PMC article.
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice.
Noy-Porat T, Mechaly A, Levy Y, Makdasi E, Alcalay R, Gur D, Aftalion M, Falach R, Leviatan Ben-Arye S, Lazar S, Zauberman A, Epstein E, Chitlaru T, Weiss S, Achdout H, Edgeworth JD, Kikkeri R, Yu H, Chen X, Yitzhaki S, Shapira SC, Padler-Karavani V, Mazor O, Rosenfeld R. Noy-Porat T, et al. iScience. 2021 May 21;24(5):102479. doi: 10.1016/j.isci.2021.102479. Epub 2021 Apr 26. iScience. 2021. PMID: 33937725 Free PMC article.
20 results